Patient-level meta-analysis: Effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism

Annals of Internal Medicine

Volumn 153, Issue 8, 2010, Pages 523-531

  Douketis, James ^a   Tosetto, Alberto ^b   Marcucci, Maura ^c   Baglin, Trevor ^d   Cushman, Mary ^e   Eichinger, Sabine ^f   Palareti, Gualtiero ^g   Poli, Daniela ^h   Tait, R Campbell ⁱ   Iorio, Alfonso ^j  

^a MCMASTER UNIVERSITY   (Canada)

^b SAN BORTOLO HOSPITAL   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h CAREGGI UNIVERSITY HOSPITAL   (Italy)

ⁱ GLASGOW ROYAL INFIRMARY   (United Kingdom)

^j MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER;

ANTICOAGULATION; CONTROLLED CLINICAL TRIAL; FOLLOW UP; HORMONAL THERAPY; HUMAN; META ANALYSIS (TOPIC); MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SEX DIFFERENCE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 78751635399     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-8-201010190-00009     Document Type: Review

References (49)

1. Snow V, Qaseem A, Barry P, Hornbake ER, Rodnick JE, Tobolic T, et al; American College of Physicians. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007;146:204-10. [PMID: 17261857]
2. Keeling D. Duration of anticoagulation: decision making based on absolute risk. Blood Rev. 2006;20:173-8. [PMID: 16271810]
3. Houman Fekrazad M, Lopes RD, Stashenko GJ, Alexander JH, Garcia D. Treatment of venous thromboembolism: guidelines translated for the clinician. J Thromb Thrombolysis. 2009;28:270-5. [PMID: 19579012]
4. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454S-545S. [PMID: 18574272]
5. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing antico-agulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007; 92:199-205. [PMID: 17296569]
6. Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, et al. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost. 2009;101:878-85. [PMID: 19404541]
7. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113:2878-87. [PMID: 19008457]
8. Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost. 2007;5 Suppl 1:41-50. [PMID: 17635707]
9. Palareti G, Cosmi B, Legnani C. D-dimer testing to determine the duration of anticoagulant therapy. Curr Opin Pulm Med. 2007;13:393-7. [PMID: 17940483]
10. Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med. 2008; 149:481-90, W94. [PMID: 18838728]
11. Lutsey PL, Folsom AR, Heckbert SR, Cushman M. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost. 2009;7:1639-48. [PMID: 19656279]
12. Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med. 2000;109:357-61. [PMID: 11020391]
13. Sud S, Douketis J. ACP Journal Club. The devil is in the details . . . or not? A primer on individual patient data meta-analysis [Editorial]. Ann Intern Med. 2009;151:JC1-2, JC1-3. [PMID: 19620147]
14. Koopman L, van der Heijden GJ, Glasziou PP, Grobbee DE, Rovers MM. A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses. J Clin Epidemiol. 2007;60:1002-9. [PMID: 17884593]
15. Smith CT, Williamson PR, Marson AG. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med. 2005; 24:1307-19. [PMID: 15685717]
16. Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, et al. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006;4:1208-14. [PMID: 16706961]
17. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355:1780-9. [PMID: 17065639] (Pubitemid 44741540)
18. Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation. 2003;108:313-8. [PMID: 12847064] (Pubitemid 36899022)
19. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA. 2003;290:1071-4. [PMID: 12941680]
20. Poli D, Antonucci E, Ciuti G, Abbate R, Prisco D. Combination of D-dimer, F1 + 2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal [Letter]. J Thromb Haemost. 2008;6:708-10. [PMID: 18194414] (Pubitemid 351404942)
21. Baglin T, Palmer CR, Luddington R, Baglin C. Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors. J Thromb Haemost. 2008;6:577-82. [PMID: 18182040] (Pubitemid 351404924)
22. Tait R, Lowe GDO, McColl MD, McMahon AD, Robertson L, King L, et al. Predicting risk of recurrent venous thrombosis using a 5-point scoring system including fibrin D-dimer. J Thromb Haemost. 2007;5:O-M-060.
23. Merlin T, Weston A, Tooher R. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'. BMC Med Res Methodol. 2009;9:34. [PMID: 19519887]
24. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224-8. [PMID: 11473921]
25. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa, Ontario, Canada: Department of Epidemiology and Community Medicine, University of Ottawa; 2009. Accessed at www.ohri.ca/ programs/clinical-epidemiology/oxford.htm on 20 August 2010.
26. Millett GA, Flores SA, Marks G, Reed JB, Herbst JH. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA. 2008;300:1674-84. [PMID: 18840841]
27. Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63:721-7. [PMID: 20338724]
28. Elias A, Bonfils S, Daoud-Elias M, Gauthier B, Sié P, Boccalon H, et al. Influence of long term oral anticoagulants upon prothrombin fragment 1+ 2, thrombin-antithrombin III complex and D-dimer levels in patients affected by proximal deep vein thrombosis. Thromb Haemost. 1993;69:302-5. [PMID: 8497840] (Pubitemid 23103112)
29. MacCallum PK, Rudnicka AR, Rumley A, Meade TW, Lowe GD. Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction. Br J Haematol. 2004;127:448-50. [PMID: 15521923] (Pubitemid 39536598)
30. Cundiff DK. Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism. Medscape J Med. 2008;10:258. [PMID: 19099008]
31. Spencer FA, Gore JM, Lessard D, Emery C, Pacifico L, Reed G, et al. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008;100:780-8. [PMID: 18989521]
32. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243-8. [PMID: 12393393] (Pubitemid 36182491)
33. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829-35. [PMID: 8182763]
34. Linkins LA, Bates SM, Ginsberg JS, Kearon C. Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost. 2004;2:1256-60. [PMID: 15304026] (Pubitemid 40186117)
35. Le Gal G, Bounameaux H. Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost. 2004;2:1244-6. [PMID: 15304024] (Pubitemid 40186115)
36. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:I9-16. [PMID: 12814980]
37. Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, et al. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost. 2010;104. [PMID: 20539910]
38. Agnelli G, Becattini C. Treatment of DVT: how long is enough and how do you predict recurrence. J Thromb Thrombolysis. 2008;25:37-44. [PMID: 17906973]
39. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, et al; Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001;345:165-9. [PMID: 11463010]
40. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, et al; Warfarin Optimal Duration Italian Trial Investigators. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med. 2003;139:19-25. [PMID: 12834314]
41. Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost. 2006;4:2629-35. [PMID: 17002663] (Pubitemid 44741559)
42. Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, et al; AESOPUS Investigators. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med. 2009;150:577-85. [PMID: 19414836]
43. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med. 2006;166:729-36. [PMID: 16606808]
44. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008;179:417-26. [PMID: 18725614]
45. Goldhaber SZ. Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized? [Editorial]. Ann Intern Med. 2009;150:644-6. [PMID: 19414845]
46. Eichinger S, Kyrle PA. Duration of anticoagulation after initial idiopathic venous thrombosis - the swinging pendulum: risk assessment to predict recurrence. J Thromb Haemost. 2009;7 Suppl 1:291-5. [PMID: 19630819]
47. Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009;28:401-9. [PMID: 19629642]
48. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:I4-8. [PMID: 12814979]
49. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611-7. [PMID: 16102026]